Skip to main content

Paradigm and Lion Win $11.7 Million NIST Grant For Bioinformatics

NEW YORK, June 11-The National Institute of Standards and Technology has awarded Paradigm Genetics and Lion Bioscience an $11.7 million grant for bioinformatics research, the two companies said today.

 

The grant, administered under the agency's Advanced Technology Program, will support a system to improve data integration and target validation in drug development.

 

By the terms of the grant, the two companies must enter into a cooperative agreement with NIST.

 

The Advanced Technology Program is designed to support high-risk research with a potentially large commercial payoff. The grant, which will be split between the two companies, is typically awarded through a peer review process. Terms generally require companies to match their half, and Paradigm said it will match its half of the booty in in-kind research.

 

In an interview with GenomeWeb at the BIO 2002 meeting Toronto this morning, John Hamer, Paradigm's interim president and CEO, said that though Lion will retina marketing rights to any products developed under the collaboration, Paradigm will receive undisclosed royalties.

 

He added that Paradigm is currently building a "project team" to coordinate the collaboration. He said he will have a team up an running in 2-3 months.

 

Kirell Lakhman in Toronto contributed to this report.

The Scan

And For Adolescents

The US Food and Drug Administration has authorized the Pfizer-BioNTech SARS-CoV-2 vaccine for children between the ages of 12 and 15 years old.

Also of Concern to WHO

The Wall Street Journal reports that the World Health Organization has classified the SARS-CoV-2 variant B.1.617 as a "variant of concern."

Test for Them All

The New York Times reports on the development of combined tests for SARS-CoV-2 and other viruses like influenza.

PNAS Papers on Oral Microbiome Evolution, Snake Toxins, Transcription Factor Binding

In PNAS this week: evolution of oral microbiomes among hominids, comparative genomic analysis of snake toxins, and more.